Abstract
Infections caused by mycobacteria produce a wide range of immunological reactions. Tuberculosis and leprosy are often considered the prototype of chronic intracellular infections, and the immunological investigation of these diseases has provided insights into the basic mechanisms of both cellular and humoral immunity (30). However, there are few diseases that so effectively express the spectrum of immune responsiveness as leprosy and, to a lesser extent, tuberculosis. Moreover, results from many BCG vaccine trials against tuberculosis and leprosy showed wide variations in protection (8). Two main hypotheses were put forward to explain the observed variations in the efficacy of vaccination: (a) variability in the potency of the strain and preparations used; and (b) the influence of previous sensitization with atypical mycobacteria. These hypotheses are favored no more, however and it is thought that the protective effect of BCG may depend on epidemiological, environment, and immunological factors affecting the infecting agents as well as the host.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adu HO, Curtis J, Turk JL: Differences in cell-mediated immune responses of “high-resistance” and “low-resistance” mice to a non pathogenic mycobacterium. Scand J Immunol 1981; 14: 467–480.
Alexander J: Adoptive transfer of immunity and suppression by cells and serum in early Mycobacterium lepraemurium infections in mice. Parasitol Immunol 1979; 1: 159–166.
Bloom BR: Learning from leprosy: a perspective on immunology and the Third World. J Immunol 1986; 137: 1–10.
Bourassa D, Forget A, Pelletier M, et al: Cellular immune responses to My¬cobacterium bovis (BCG) in genetically susceptible and resistant congenic mouse strains. Clin Exp Immunol 1985; 62: 31–38.
Brown IN: Animal models and immune mechanisms in mycobacterial infec¬tions, in Ratledge C, Stanford JL (eds): Biology of Mycobacteria. London, Academic Press, 1983; vol 2, pp. 173–234.
Brown IN, Glynn AA, Plant JE: Inbred mouse strain resistance to Mycobac¬terium lepraemurium follows the Ity/Lsh pattern. Immunology 1982, 47: 149–156.
Chaparas SD: The immunology of mycobacterial infections. CRC Crit Rev Microbiol 1982; 9: 139–197.
Clemens JD, Chuong JJH, Feinstein AR: The BCG controversy: a method¬ological and statistical reappraisal. JAMA 1983; 249: 2362–2369.
Collins FM: Acquired resistance to mycobacterial infections. Adv Tuberc Res 1972; 18: 1–30.
Collins FM, Montalbine V: Relative immunogenicity of streptomycin-susceptible and resistant strains of BCG. II. Effect of the route of immunization on growth and immunogenicity. Am Rev Respir Dis 1975; 111: 43–51.
Collins FM: The immunology of tuberculosis. Am Rev Respir Dis 1982; 25 (suppl 3): 42–49.
Daniel TM: The immunology of tuberculosis. Clin Chest Med 1980; 1: 189–201.
Denis M, Forget A, Pelletier M, et al: Control of the BCG gene of early re¬sistance in mice to infection with BCG substrains and atypical mycobacteria. Clin Exp Immunol 1986; 63: 517–525.
Douvas GS, Lookes DL, Vatter AE, Crowle AJ: Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophages associated mycobacteria. Infect Immun. 1985; 50: 1–8.
Edden W van, Gonzalez NM, De Vries RRP, et al: HLA linked control of predisposition to lepromatous leprosy. J Infect Dis 1985; 151: 9–14
Edwards ML, Goodrich JM, Muller A, et al: Infection with Mycobacterium avium-intracellulare and the protective effect of bacille Calmette-Guérin. J Infect Dis 1982; 145: 733–741.
Forget A, Benoit JC, Turcotte R, Gusew-Chartrand N: Enhancement activity of antimycobacterial sera in experimental Mycobacterium bovis (BCG) infec¬tion in mice. Infect Immun 1976; 13: 1301–1306.
Forget A, Turcotte R, Benoit JC, Borduas AG: Enhancing effect of passive immunization with mycobacterial antibodies on humoral and cellular immunity in BCG-infected mice. Ann Immunol (Inst Pasteur) 1978; 129G: 255–265.
Gros P, Skamene E, Forget A: Genetic control of natural resistance to My¬cobacterium bovis (BCG) in mice. J Immunol 1981; 127: 2417–2431.
Hahn H, Kaufmann SHE: The role of cell-mediated immunity in bacterial infections. Rev Infect Dis 1981; 3: 1221–1250.
Hawrylko E, Mackaness GB: The kinetics of lymphoïd proliferation in tu¬berculosis mouse spleen cells. Cell Immunol 1972; 5: 148–170.
Howard JG, Hale C, Liew FY: Immunological regulation of experimental cu¬taneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica J Exp Med 1981; 153: 557–568.
Hurtrel B, Hurtrel M, Lagrange PH: Genetic control of tuberculin time course in mice, correlation with natural and acquired resistance against BCG, in Skamene E (ed): Genetic control of Host Resistance to Infection and Malignancy. New York, Alan R. Liss, 1985, pp 305–312.
Kiderlen AF, Kaufmann SHE, Lohmann-Matthes ML: Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol 1984; 14: 964–967.
Kingston AE, Stagg AJ, Colston MJ: Investigation of antigen cross-reactivity of Mycobacterium leprae reactive murine T cell lines and clones. Immunology 1986; 58: 217–223.
Lagranse PH, Hurtrel B: Local immune response to Mycobacterium leprae murium in C3H and C57B1/6 mice. Clin Exp Immunol 1979; 38: 461–474.
Lagrange PH, Hurtrel B, Ravisse P, Grosset J: A single subcutaneous inoc¬ulation of 107 armadillo derived irradiated Mycobacterium leprae evokes dif¬ferent immunological behavior in C57B1/6 and C3H mice. Ann Inst Pasteur Microbiol 1982; 1338: 167–168.
Lagranse PH, Hurtrel B, Brandely M, Thickstun PM: Immunological mech¬anisms controlling mycobacterial infections. Bull Eur Physiopathol Respir 1983; 19: 163–172.
Lagrange PH, Hurtrel B: Anergy and other immunological perturbances in mycobacterial infections: an overview, in Friedman H, Bendinelli M (eds): Tuberculosis: Interactions with the Immune System. New York, Plenum, 1988. pp 171–205.
Lagrance PH, Hurtrel B: Induction of protective immunity to mycobacterial infection. Lepr Rev 1986; 57: 231–244.
Lefford MJ: The effect of inoculum size on the immune response to BCG infection in mice. Immunology 1970; 21: 369–381.
Lefford MJ: Transfer of adoptive immunity to tuberculosis in mice. Infect Immun 1975; 11: 1175–1181.
Lefford MJ: Induction and expression of immunity after BCG immunization. Infect Immun 1977; 18: 646–653.
Naher H, Sperling U, Hahn H: H2k restricted granuloma formation by Ly2 + T cells in antibacterial protection to facultative intracellular bacteria J Immunol 1985; 135: 569–572.
Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon gamma as the lymphokine that activates human macrophage oxidative me¬tabolism and antimicrobial activity. J Exp Med 1983; 158: 670–689.
Orme IM, Collins FM: Infection with Mycobacterium kansaii and efficacy of vaccination against tuberculosis. Immunology 1983; 50: 581–586.
Orme IM, Ratcliffe MJH, Collins FM: Acquired immunity to heavy infection with Mycobacterium bovis, bacillus Calmette-Guérin, and its relationship to the development of non specific unresponsiveness in vitro. Cell Immunol 1984; 88: 285–296.
Orme IM, Collins FM: Cross protection against non-tuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T-lymphocytes. J Exp Med 1986; 163: 203–208.
Palmer CE, Long MW: Effect of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis 1966; 94: 533–568.
Patel PJ, Lefford MJ: Specific and non specific resistance in mice immunized with irradiated Mycobacterium leprae. Infect Immun 1978; 20: 692–697.
Pelletier M, Forget A, Bourassa D, et al: Immunopathology of BCG infection in genetically resistant and susceptible mouse strains. J Immunol 1982; 129: 2179–2185.
Reggiardo Z, Middlebrook G: Failure of passive serum transfer of immunity against aerogenic tuberculosis in rabbits. Proc Soc Exp Biol Med 1974; 145: 173–175.
Rook GAW, Bahr GM, Stanford JL: The effects of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle 1981; 62: 63–68.
Rook GAW: Suppressor cells of mouse and man—What is the evidence that they contribute to the aetiology of the mycobacterioses?Lepr Rev 1982; 53: 306–312.
Rook GAW: An integrated view of the immunology of the mycobacterioses in guinea-pigs, mice and men, in Ratledge C, Stanford JL (eds): Biology of Mycobacteria. London, Academic Press, 1983, vol 2, pp 279–319.
Sheppard CC, Walker L, van Landingham RM: Heat stability of Mycobac¬terium leprae immunogenicity. Infect Immun 1978; 22: 87–93.
Skamene E, Gros P: Role of macrophages in resistance against infectious diseases. Clin Immunol Allergy 1983; 3: 539–560.
Skamene E: Genetic control of resistance to mycobacterial infection. Curr Top Microbiol Immunol 1986; 124: 49–66.
Smith DW: Animal models for study immunity in infection disease. J Infect Dis 1973; 128: 800–801.
Stach JL, Delgado G, Tchibozo V, et al: Natural resistance to mycobacteria: antimicrobial activity and reactive oxygen intermediate releasing function of murine macrophages. Ann Inst Pasteur Immunol 1984; 135D: 25–37.
Stach JL, Gros P, Forget A, Skamene E: Phenotypic expression of genetically controlled natural resistance to Mycobacterium bovis. J Immunol 1984; 132: 888–892.
Stanford JL, Shield MJ, Rook GAW: How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 1981; 62: 55–62.
Suga M, Dannenberg AM, Higuchi S: Macrophage functional heterogeneity in vivo. Am J Pathol 1980; 99: 305–324.
Sultzer BM, Nilsson B: PPD tuberculin—a B cell mitogen. Nature 1972; 240n: 198–200.
WHO: Immunological research in tuberculosis: memorandum from a WHO meeting. Bull WHO 1982; 60: 723–727.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc
About this paper
Cite this paper
Lagrange, P.H., Hurtrel, B. (1989). Immunity in Tuberculosis: Environmental Versus Intrinsic Factors Modulating the Immune Responsiveness to Mycobacteria. In: Talwar, G.P. (eds) Progress in Vaccinology. Progress in Vaccinology, vol 2. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3508-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3508-8_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-96734-9
Online ISBN: 978-1-4612-3508-8
eBook Packages: Springer Book Archive